Skip to main content
OpenTrials
Completed

NCT Number: NCT01428206

Liverpool Care Pathway for the Dying at Residential Care Homes

Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

End-of-life Care

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Skellefteå municipality

Skellefteå, Västerbotten County, Sweden

About this study

All residential care homes in Skellefteå municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • nursing homes in Skellefteå municipality, Sweden

Exclusion criteria

-

Treatment and study plan

Liverpool care pathway

Other

Liverpool care pathway is started tha last day in life for elderly at nursing homes

Other names: end-of-life care, palliative care

Primary outcomes

  1. quality of care

    Time frame: one month to six months after the relatives death

    changes between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative

Secondary outcomes

  1. place of death

    Time frame: the time of death

    changes between the groups

  2. drug consumption

    Time frame: the last three days before death

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Registry information

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Sep 2, 2011
Registry last updated
Jun 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.